Nivolumab Induces Tumor Evolution in Patients with Melanoma [Immunotherapy]

Nivolumab treatment results in immunoediting and loss of tumor cells expressing neoantigens.

from Cancer via ola Kala on Inoreader http://ift.tt/2Art90M
via IFTTT